exc 001
Nucleic acidexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2009 (NCT01037413)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Connective tissue growth factorINHIBITOR
CCN2 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- exc 001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01494922 | Phase 2 | Dec 1, 2011 | Pfizer |
| NCT01346969 | Phase 2 | Jun 1, 2011 | Pfizer |
| NCT01037413 | Phase 2 | Nov 1, 2009 | Pfizer |
| NCT01037985 | Phase 2 | Nov 1, 2009 | Pfizer |
| NCT01038297 | Phase 2 | Nov 1, 2009 | Pfizer |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 5 | 5 | 1 | 2009 |
1 organizations
Page 1 / 1